Clinical Trial Update: Severe Necrotizing Enterocolitis in Preterm Newborns <1500g Using Probiotics [Phase 2]

View source ↗

Summary

Phase 2 trial assessing probiotics for severe necrotizing enterocolitis in preterm newborns under 1500 g has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Necrotizing Enterocolitis

Snippet

Sponsor: Coordinación de Investigación en Salud, Mexico | Conditions: Infectious Diseases | Phase 2 | Status: COMPLETED